All Posts

WASHINGTON, DC – Energy and Commerce Chariman Greg Walden (R-OR) and Subcommittee on Health Chairman Michael C. Burgess M.D. (R-TX) released the following statement after President Donald Trump today signed two important bills into law, S. 2553 the Know the Lowest Price Act of 2018, and S. 2554 the Patient Right to Know Drug Prices Act.

“Health care is an important and personal aspect of a patient’s life, and we should always work to improve transparency and accountability throughout our system,” said Chairman Walden, and #SubHealth Chairman...

Excerpt: "On June 15, 2018, the Subcommittee on Oversight and Investigations held a hearing on bio-preparedness. The FDA Chief Scientist testified at that hearing, including about the FDA OLSS. During the hearing, the FDA Chief Scientist acknowledged that, although the FDA has about 2,800 laboratory spaces, the OLSS had not conducted any inspections of these spaces over the last year. Further, the Chief Scientist testified that OLSS had only three permanent staff, not the 13 FTEs that the FDA had committed for OLSS in a September 2016 letter to...

WASHINGTON, DC –Today, the House passed sweeping, bipartisan legislation to combat the opioid crisis. H.R. 6, the SUPPORT for Patients and Communities Act, authored by Energy and Commerce Committee Chairman Greg Walden (R-OR), now heads to the Senate for a final vote and then to the President’s desk to be signed into law.

Chairman Walden and Health Subcommittee Chairman Michael C. Burgess, M.D. (R-TX) issued the following statement following the House passage of this historic, bipartisan legislative package.

“Seldom can we say that federal legislation will actually save...